Engineering the future of 3D pathology
The Journal of Pathology: Clinical Research · 2024-01 · 10 (1)
DOI: 10.1002/cjp2.347 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Journal of Pathology: Clinical Research, online erschienen am 02.11.2023. Verfasst von Jonathan Tc Liu und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Mechanical Engineering, University of Washington, Seattle, WA, USA. Hauptthemen laut MEDLINE: Artificial Intelligence, Microscopy. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIDDK NIH HHS, NCI NIH HHS, NLM NIH HHS.
Abstract (Originalsprache)
In recent years, technological advances in tissue preparation, high‐throughput volumetric microscopy, and computational infrastructure have enabled rapid developments in nondestructive 3D pathology, in which high‐resolution histologic datasets are obtained from thick tissue specimens, such as whole biopsies, without the need for physical sectioning onto glass slides. While 3D pathology generates massive datasets that are attractive for automated computational analysis, there is also a desire to use 3D pathology to improve the visual assessment of tissue histology. In this perspective, we discuss and provide examples of potential advantages of 3D pathology for the visual assessment of clinical specimens and the challenges of dealing with large 3D datasets (of individual or multiple specimens) that pathologists have not been trained to interpret. We discuss the need for artificial intelligence triaging algorithms and explainable analysis methods to assist pathologists or other domain experts in the interpretation of these novel, often complex, large datasets.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Mechanical Engineering, University of Washington, Seattle, WA, USA.
- Department of Laboratory Medicine & Pathology, University of Washington School of Medicine, Seattle, USA.
- Department of Bioengineering, University of Washington, Seattle, USA.
- John Radcliffe Hospital, University of Oxford, Oxford, UK.
- Sunnybrook Health Sciences Centre, University of Toronto, Toronto, Canada.
- Public Health Agency of Catalonia, Lleida, Spain.
ORCID-Profile: Jonathan Tc Liu, Sarah Sl Chow, Xavier Farré, Clare Verrill
Förderung
- NIDDK NIH HHS
- NCI NIH HHS
- NLM NIH HHS
- Prostate Cancer UK
- NIBIB NIH HHS
- Canary Foundation
- Division of Cancer Prevention, National Cancer Institute
- National Institute of Biomedical Imaging and Bioengineering
Zitieren
APA
Liu, J. T., Chow, S. S., Colling, R., Downes, M. R., Farré, X., Humphrey, P., Janowczyk, A., Mirtti, T., Verrill, C., Zlobec, I., & True, L. D. (2024). Engineering the future of 3D pathology. The Journal of Pathology: Clinical Research, 10(1). https://doi.org/10.1002/cjp2.347
Vancouver
Liu JT, Chow SS, Colling R, Downes MR, Farré X, Humphrey P, et al. Engineering the future of 3D pathology. The Journal of Pathology: Clinical Research. 2024;10(1). doi:10.1002/cjp2.347
BibTeX
@article{Liu2024,
author = {Liu, Jonathan Tc and Chow, Sarah Sl and Colling, Richard and Downes, Michelle R and Farré, Xavier and Humphrey, Peter and Janowczyk, Andrew and Mirtti, Tuomas and Verrill, Clare and Zlobec, Inti and True, Lawrence D},
title = {Engineering the future of 3D pathology},
journal = {The Journal of Pathology: Clinical Research},
year = {2024},
volume = {10},
number = {1},
doi = {10.1002/cjp2.347}
}
EUVIMED